Here are the allocation amounts per disease component for Global Fund-eligible Asia-Pacific countries. These amounts represent the level of funding that Country Coordinating Mechanisms or CCMs may apply for, with certain conditions, such as the application focus of the funding requests, or the country’s fulfilment of its co-financing commitments in the previous Allocation Period (2014-2016). Note that under the new Global Fund strategy, on top of these allocations, there are other opportunities for countries to expand their Global Fund resource envelopes.

One of these is the Catalytic Investment Funding, a matching fund that is available for a pre-selected set of countries to incentivise them to use their country allocations to implement programmes that are strategic to the Global Fund and its partners. These priorities include scaling up of evidence-informed HIV programmes for key and vulnerable populations, removing human rights barriers in access to HIV services, programs to address HIV amongst adolescent girls and young women, finding the missing TB and drug resistant TB cases and contributing to resilient and sustainable systems for health.

The other available funding stream is through portfolio optimisation. Countries must now submit a prioritised above allocation request (or, a list of priority activities that are above allocation amounts), so that this additional request can be evaluated, pre-approved, and prioritised for potential funding in case there are efficiencies in the portfolio or if there are available resources for reinvestment. Check out our Community Starter Kit if you want to read more about these ‘evolutions’ in the Global Fund funding model and processes. Don’t hesitate to email us or contact us on Facebook if you have questions and suggestions!

Regional Summary

Total allocation for the region: US$1,926,068,492 (Note: excluding Afghanistan and Iran)

Disease components

HIV

$614,701,656

TB

$937,096,846

Malaria

$374,269,990

Income classification

Low income

$169,820,058

Lower-LMICs

$1,304,102,233

Upper-LMICs

$373,934,891

Upper MICs

$65,270,564

*Excluding the Western Pacific multi-country allocations

Sub-regions

East Asia

$54,332,735

Southeast Asia

$906,700,112

South Asia

$908,955,188

Pacific

$56,080,457

 

COUNTRY ALLOCATIONS

HIV

TB

Malaria

Total

Bangladesh

18,295,447

97,935,663

30,000,000

146,231,110

Bhutan

1,081,903

1,074,146

1,432,470

3,588,519

Cambodia

41,597,533

13,812,665

28,034,953

83,445,151

DPR Korea

35,979,788

8,083,880

44,063,668

India

155,063,624

279,929,924

65,006,452

500,000,000

Indonesia

91,934,562

102,416,537

53,644,906

247,996,005

Lao PDR

7,374,096

7,393,149

8,321,441

23,088,686

Malaysia

4,031,592

4,031,592

Mongolia

3,044,708

7,224,359

10,269,067

Myanmar

123,102,465

82,947,503

56,159,469

262,209,437

Nepal

21,964,144

16,138,548

4,208,547

42,311,239

Pakistan

34,956,107

130,163,215

39,232,878

204,352,200

Papua New Guniea

8,211,639

11,364,975

23,563,097

43,139,711

Philippines

8,483,242

78,543,887

10,662,817

97,689,946

Sri Lanka

6,948,047

3,024,073

2,500,000

12,472,120

Thailand

24,569,150

13,096,509

13,304,246

50,969,905

Timor Leste

2,312,598

2,494,891

10,969,331

15,776,820

Vietnam

56,638,006

47,281,094

17,573,470

121,492,570

Western Pacific Region

5,092,793

6,275,920

1,572,033

12,940,746

*The malaria components for Cambodia, Lao PDR, Myanmar, Thailand, and Vietnam will be managed under the Regional Artemisinin-resistance Initiative (RAI) programme, which adds up to US$123,393,579. The RAI programme also includes a catalytic multi-country investment worth US$119 million.

** The Western Pacific Region multicountry grants include Kiribati, Marshall Is., Micronesia, Palau, Samoa, Tonga. Tuvalu and Vanuatu.